Titlebook: Atlas of Imaging in Cardio-Oncology; Case-Based Study Gui Richard M. Steingart,Jennifer E. Liu Book 2021 Springer Nature Switzerland AG 202

aspirant

書(shū)目名稱Atlas of Imaging in Cardio-Oncology影響因子(影響力)




書(shū)目名稱Atlas of Imaging in Cardio-Oncology影響因子(影響力)學(xué)科排名




書(shū)目名稱Atlas of Imaging in Cardio-Oncology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Atlas of Imaging in Cardio-Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Atlas of Imaging in Cardio-Oncology被引頻次




書(shū)目名稱Atlas of Imaging in Cardio-Oncology被引頻次學(xué)科排名




書(shū)目名稱Atlas of Imaging in Cardio-Oncology年度引用




書(shū)目名稱Atlas of Imaging in Cardio-Oncology年度引用學(xué)科排名




書(shū)目名稱Atlas of Imaging in Cardio-Oncology讀者反饋




書(shū)目名稱Atlas of Imaging in Cardio-Oncology讀者反饋學(xué)科排名

修改

studies presented by practitioners from around the globe to .This atlas provides a practically applicable didatic case-based guide to the use of cardiac imaging in patient care during and after cancer therapy. It features detailed information on a variety of imaging modalities,?including transesopha

嘴唇可修剪

事與愿違

acrobat

Nicole C. Panarelli,Rhonda K. Yantisses not often afford such a luxury in that most clinical presentations involving ventricular dysfunction have multifactorial determinants. Exploring the entity of stress cardiomyopathy provides a good conceptual framework for the examination of acute ventricular dysfunction in cancer patients.

conspicuous

Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy,nts (axicabtagene ciloleucel, tisagenlecleucel, brexucabtagene autoleucel, lisocabtagene maraleucel) are CD-19-directed. Cardio-oncologists should familiarize themselves with surveillance strategies for cardiovascular events following CAR T-cell therapy, given the risk for de novo arrhythmia and heart failure.

originality

Focus-Words

感染

Biguanides

https://doi.org/10.1007/978-3-658-36308-6instay of treatment involving cessation of the ICI and the administration of corticosteroids. The three cases presented below will highlight differences in clinical presentations, diagnostic tests, and treatments followed by an in-depth discussion of these differences.